Latest Versant Venture Management, LLC Stock Portfolio
Versant Venture Management, LLC Performance:
2024 Q3: -4.33%YTD: -23.64%2023: -2.99%
Performance for 2024 Q3 is -4.33%, and YTD is -23.64%, and 2023 is -2.99%.
About Versant Venture Management, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Versant Venture Management, LLC reported an equity portfolio of $63.6 Millions as of 30 Sep, 2024.
The top stock holdings of Versant Venture Management, LLC are CRSP, , RPTX. The fund has invested 36.8% of it's portfolio in CRISPR THERAPEUTICS AG and 27.6% of portfolio in CONTINEUM THERAPEUTICS, INC.
The fund managers got completely rid off PASSAGE BIO, INC. (PASG) and ALIGOS THERAPEUTICS, INC. (ALGS) stocks.
The top stock holdings of Versant Venture Management, LLC are CRSP, , RPTX. The fund has invested 36.8% of it's portfolio in CRISPR THERAPEUTICS AG and 27.6% of portfolio in CONTINEUM THERAPEUTICS, INC.
The fund managers got completely rid off PASSAGE BIO, INC. (PASG) and ALIGOS THERAPEUTICS, INC. (ALGS) stocks.
Versant Venture Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Versant Venture Management, LLC made a return of -4.33% in the last quarter. In trailing 12 months, it's portfolio return was -25.74%.
New Buys
Additions
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| passage bio, inc. | -3,197,780 |
| aligos therapeutics, inc. | -510,278 |
Versant Venture Management, LLC got rid off the above stocks
Sector Distribution
Versant Venture Management, LLC has about 60% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 60 |
| Others | 40 |
Market Cap. Distribution
Versant Venture Management, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 40 |
| MID-CAP | 36.8 |
| MICRO-CAP | 23.2 |
Stocks belong to which Index?
About 3.2% of the stocks held by Versant Venture Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 96.8 |
| RUSSELL 2000 | 3.2 |
Versant Venture Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Versant Venture Management, LLC
Versant Venture Management, LLC has 6 stocks in it's portfolio. CRSP proved to be the most loss making stock for the portfolio. RPTX was the most profitable stock for Versant Venture Management, LLC last quarter.
Last Reported on: 08 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ADVM | adverum biotechnologies, inc. | 5.60 | 506,821 | 3,557,880 | unchanged | 0.00 | ||
| ALGS | aligos therapeutics, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CRSP | crispr therapeutics ag | 36.84 | 498,558 | 23,422,300 | unchanged | 0.00 | ||
| GRTS | gritstone oncology, inc. | 3.25 | 3,561,150 | 2,065,110 | unchanged | 0.00 | ||
| PASG | passage bio, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RPTX | repare therapeutics, inc. | 14.32 | 2,646,660 | 9,104,500 | unchanged | 0.00 | ||
| SKYE | skye bioscience, inc. | 12.35 | 2,007,700 | 7,850,120 | unchanged | 0.00 | ||
| contineum therapeutics, inc. | 27.64 | 918,163 | 17,573,600 | unchanged | 0.00 | |||